[1]
Łomiak, M. et al. 2023. Lipid profile after switching from a TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV. Journal of Medical Science. 92, 4 (Sep. 2023), e808. DOI:https://doi.org/10.20883/medical.e808.